We understand that antimicrobial resistance (AMR) is more than just a scientific challenge, it is a deeply personal one. 

We welcome inquiries from potential investors, prospective partners and anyone who would like to understand the science behind our groundbreaking research. 

By sharing information and speaking openly about the reality of AMR, we can break the silence surrounding this crisis.